CVS Health Up 22.5% YTD

CVS Health Corporation has outperformed the Nasdaq Composite over the past three months and year-to-date, with its shares gaining 22.5% year-to-date and 32.6% over the past 52 weeks. The company's market capitalization stands at $80.1 billion.

The company's stock has climbed 6.4% over the past three months, significantly outperforming the Nasdaq Composite, which declined 1% during the same period. Despite this, CVS Health's stock has slipped 12.2% from its 52-week high of $110.68.

CVS Health serves more than 100 million people through local and national channels, using pharmacies, technology, and connected services to improve health outcomes and make care more convenient. The company reported adjusted EPS of $2.58 in Q2, surpassing Wall Street expectations of $1.87, and total revenue of $106.1 billion in Q2.

## Why it matters The company's outperformance of the Nasdaq Composite is notable, given the index's gains of 14.4% year-to-date and 23.7% over the past year. CVS Health's improving operating performance and extensive network of convenient locations have contributed to its market leadership in the healthcare plans industry.

The company's partnership with Teladoc and focus on digital health services have further strengthened its ability to provide convenient, technology-driven healthcare and attract modern consumers. As a large-cap stock with a market capitalization exceeding $80 billion, CVS Health's performance has significant implications for investors and the broader healthcare industry.